Conversation with The Cancer Letter Gary Schwartz talks about his vision for Case CCC, leaving New York, his illustrious father—and Isaac Asimov April 07, 2023Vol.49 No.14By Paul Goldberg
NCI NCI Director Bertagnolli designs Cancer Plan to trigger national conversation, transform cancer research and care April 07, 2023Vol.49 No.14By Matthew Bin Han Ong
“Historic” cisplatin shortage leaves oncologists guessing whether they will have enough to treat the next patient April 07, 2023Vol.49 No.14By Jacquelyn Cobb
Guest Editorial Leading a matrix cancer center: Extensive responsibility, modest influence, little authority April 07, 2023Vol.49 No.14By George J. Weiner
Texas federal judge invalidates ACA preventive care mandate—USPSTF, cancer screening, and PrEP in jeopardy March 31, 2023Vol.49 No.13By Matthew Bin Han Ong
Conversation with The Cancer Letter Harvard’s Carmel Shachar: Texas ruling that guts ACA preventive care likely to reach Supreme Court—and be upheld March 31, 2023Vol.49 No.13By Matthew Bin Han Ong
Conversation with The Cancer Letter NYU’s Art Caplan: Texas ruling that nixes USPSTF authority embodies “bigotry, hatred, and ignorance” March 31, 2023Vol.49 No.13By Matthew Bin Han Ong
Conversation with The Cancer LetterRegulatory News FDA’s Fashoyin-Aje: Draft guidance on accelerated approval urges reliance on randomized controlled trials March 31, 2023Vol.49 No.13By Jacquelyn Cobb
